No takes yet. Share an insight, caveat, or question.
Highlights the concerning trend of prescribing contraindicated direct oral anticoagulants (dabigatran and rivaroxaban) to hemodialysis patients with atrial fibrillation without supporting evidence.
Chan et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: